Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient
- 1 August 2007
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 49 (2), 210-212
- https://doi.org/10.1002/pbc.20640
Abstract
Aplastic anemia (AA) is mediated by T‐cell autoimmunity in the majority of cases; it is rare and mostly idiopathic in children. We describe a child, who developed AA following Graves' disease which could not be attributed to antithyroid drugs. We hypothesized that both diseases were caused by similar autoimmune process. We monitored the blood counts and did not administer any conventional treatment for AA assuming that the existing anti‐ hematopoietic stem cell humoral and cellular immunity might subside with induction of remission of Grave's disease. The child went into complete remission with the treatment of the Graves' disease. Pediatr Blood Cancer 2007;49:210–212.Keywords
This publication has 9 references indexed in Scilit:
- Autoantibodies frequently detected in patients with aplastic anemiaBlood, 2003
- Severe Aplastic Anemia with Autoimmune Thyroiditis Showing No Hematological Response to Intensive Immunosuppressive TherapyActa Haematologica, 2003
- Severe aplastic anaemia and Grave's disease in a paediatric patientBritish Journal of Haematology, 2002
- Acquired Aplastic AnemiaPublished by American Medical Association (AMA) ,1999
- Graves’ disease following successful treatment of severe aplastic anaemia with antilymphocyte globulinClinical and Laboratory Haematology, 1999
- Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemiaAnnals of Hematology, 1995
- Coincidence of Severe Aplastic Anaemia with Multiple Sclerosis or Thyroid DisordersActa Haematologica, 1994
- Concordant Graves' Disease after Bone Marrow Transplantation: Implications for PathogenesisJournal of Clinical Endocrinology & Metabolism, 1991